First, we detected tumor specific CD8+ T population by tetramer staining assay, and the results showed that gCpG + OVA treatment significantly increased tumoral infiltration of OVA-specific CD8+ T (Fig. 4a). The gene discussed is CD8A; the disease is neoplasm.